Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
NJ; BJOG: Int J Obstet Gy; July, 2022. 10 p. tab. (PCI-277).
Não convencional em Inglês | REPincaP, LIGCSA | ID: biblio-1400934

RESUMO

Objective: To assess, on a population basis, the medical care for pregnant women in specific geographic regions of six countries before and during the first year of the coronavirus disease 2019 (COVID-19) pandemic in relationship to pregnancy outcom. Results: Across all sites, a small but statistically significant increase in home births occurred between the pre-COVID-19 and COVID-19 periods (18.9% versus 20.3%, adjusted relative risk [aRR] 1.12, 95% CI 1.05­1.19). A small but significant decrease in the mean number of antenatal care visits (from 4.1 to 4.0, p = <0.0001) was seen during the COVID-19 period. Of outcomes evaluated, overall, a small but significant decrease in low-birthweight infants in the COVID-19 period occurred (15.7% versus 14.6%, aRR 0.94, 95% CI 0.89­0.99), but we did not observe any significant differences in other outcomes. There was no change observed in maternal mortality or antenatal haemorrhage overall or at any of the sites. Conclusions: Small but significant increases in home births and decreases in the antenatal care services were observed during the initial COVID-19 period; however, there was not an increase in the stillbirth, neonatal mortality, maternal mortality, low birthweight, or preterm birth rates during the COVID-19 period compared with the previous year. Further research should help to elucidate the relationship between access to and use of pregnancy-related medical services and birth outcomes over an extended period


Assuntos
Cuidados Médicos , Gestantes , Pandemias , Estudo Observacional , COVID-19
2.
Durham, NC; BJOG; 2022. 9 p. tab, graf. (PCI-278).
Não convencional em Inglês | REPincaP, LIGCSA | ID: biblio-1401039

RESUMO

Objective. We sought to understand knowledge, attitudes and practices (KAP) regarding COVID-19 in pregnant women in seven low and middle-income countries (LMIC). Results. In all, 25 260 women completed the survey. Overall, 56.8% of women named ≥3 COVID-19 symptoms, 34.3% knew ≥2 transmission modes, 51.3% knew ≥3 preventive measures and 79.7% named at least one high-risk condition. Due to COVID-19 exposure concerns, 23.8% had avoided prenatal care and 7.5% planned to avoid hospital delivery. Over half the women in the Guatemalan site and 40% in the Pakistan site reduced care seeking due to COVID-19 exposure concerns. Of the women, 24.0% were afraid of getting COVID-19 from healthcare providers. Overall, 63.3% reported wearing a mask and 29.1% planned to stay at home to reduce COVID-19 exposure risk


Assuntos
Conhecimentos, Atitudes e Prática em Saúde , Saúde da Criança , Estudos Transversais , Gestantes , COVID-19
3.
Epidemiol Infect ; 146(6): 688-697, 2018 04.
Artigo em Inglês | MEDLINE | ID: mdl-29534766

RESUMO

Improving understanding of the pathogen-specific seasonality of enteric infections is critical to informing policy on the timing of preventive measures and to forecast trends in the burden of diarrhoeal disease. Data obtained from active surveillance of cohorts can capture the underlying infection status as transmission occurs in the community. The purpose of this study was to characterise rotavirus seasonality in eight different locations while adjusting for age, calendar time and within-subject clustering of episodes by applying an adapted Serfling model approach to data from a multi-site cohort study. In the Bangladesh and Peru sites, within-subject clustering was high, with more than half of infants who experienced one rotavirus infection going on to experience a second and more than 20% experiencing a third. In the five sites that are in countries that had not introduced the rotavirus vaccine, the model predicted a primary peak in prevalence during the dry season and, in three of these, a secondary peak during the rainy season. The patterns predicted by this approach are broadly congruent with several emerging hypotheses about rotavirus transmission and are consistent for both symptomatic and asymptomatic rotavirus episodes. These findings have practical implications for programme design, but caution should be exercised in deriving inferences about the underlying pathways driving these trends, particularly when extending the approach to other pathogens.


Assuntos
Análise por Conglomerados , Transmissão de Doença Infecciosa , Infecções por Rotavirus/epidemiologia , Estações do Ano , África/epidemiologia , Ásia/epidemiologia , Pré-Escolar , Estudos de Coortes , Humanos , Lactente , Recém-Nascido , Prevalência , Infecções por Rotavirus/transmissão , América do Sul/epidemiologia
5.
Am J Epidemiol ; 147(7): 660-9, 1998 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-9554605

RESUMO

Studies in Taiwan and Argentina suggest that ingestion of inorganic arsenic from drinking water results in increased risks of internal cancers, particularly bladder and lung cancer. The authors investigated cancer mortality in a population of around 400,000 people in a region of Northern Chile (Region II) exposed to high arsenic levels in drinking water in past years. Arsenic concentrations from 1950 to the present were obtained. Population-weighted average arsenic levels reached 570 microg/liter between 1955 to 1969, and decreased to less than 100 microg/liter by 1980. Standardized mortality ratios (SMRs) were calculated for the years 1989 to 1993. Increased mortality was found for bladder, lung, kidney, and skin cancer. Bladder cancer mortality was markedly elevated (men, SMR = 6.0 (95% confidence interval (CI) 4.8-7.4); women, SMR = 8.2 (95% CI 6.3-10.5)) as was lung cancer mortality (men, SMR = 3.8 (95% CI 3.5-4.1); women, SMR = 3.1 (95% CI 2.7-3.7)). Smoking survey data and mortality rates from chronic obstructive pulmonary disease provided evidence that smoking did not contribute to the increased mortality from these cancers. The findings provide additional evidence that ingestion of inorganic arsenic in drinking water is indeed a cause of bladder and lung cancer. It was estimated that arsenic might account for 7% of all deaths among those aged 30 years and over. If so, the impact of arsenic on the population mortality in Region II of Chile is greater than that reported anywhere to date from environmental exposure to a carcinogen in a major population.


Assuntos
Arsênio/efeitos adversos , Neoplasias Pulmonares/induzido quimicamente , Neoplasias Pulmonares/mortalidade , Vigilância da População/métodos , Neoplasias da Bexiga Urinária/induzido quimicamente , Neoplasias da Bexiga Urinária/mortalidade , Poluentes Químicos da Água/efeitos adversos , Adulto , Idoso , Idoso de 80 Anos ou mais , Arsênio/análise , Causas de Morte , Chile/epidemiologia , Métodos Epidemiológicos , Feminino , Humanos , Neoplasias Pulmonares/epidemiologia , Masculino , Pessoa de Meia-Idade , Fatores de Risco , Neoplasias da Bexiga Urinária/epidemiologia , Poluentes Químicos da Água/análise
6.
Arch Med Res ; 23(2): 281-3, 1992.
Artigo em Inglês | MEDLINE | ID: mdl-1340315

RESUMO

Genotypic differences between invasive and non-invasive E. histolytica could explain the 1:10 ratio of symptomatic/asymptomatic infection worldwide. Currently, zymodeme analysis is used to differentiate invasive from non-invasive E. histolytica strains but the technique is cumbersome and expensive. In accordance with the WHO research priorities for amebiasis we report here the further use of an invasive-specific monoclonal antibody against E. histolytica in immunofluorescence, to identify isolates cultured from stool samples of patients from three geographically distant endemic regions: Bangladesh, Colombia and Mexico. We tested 107 E. histolytica isolates and the correlation between zymodeme characterization and the immunofluorescence assay was 100%.


Assuntos
Anticorpos Monoclonais/imunologia , Anticorpos Antiprotozoários/imunologia , Disenteria Amebiana/parasitologia , Entamoeba histolytica/imunologia , Imunofluorescência , Animais , Bangladesh/epidemiologia , Colômbia/epidemiologia , Disenteria Amebiana/epidemiologia , Entamoeba histolytica/enzimologia , Entamoeba histolytica/genética , Entamoeba histolytica/isolamento & purificação , Entamoeba histolytica/patogenicidade , Fezes/parasitologia , Isoenzimas/análise , México/epidemiologia , Proteínas de Protozoários/análise , Virulência
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA